Infosys is completing the acquisition of Kaleidoscope Innovation

Infosys acquires Kaleidoscope

This collaboration also aims to revolutionize patient care, treatment, diagnostic tools and consumer health around the world.

Infosys today announced it has completed the acquisition of Kaleidoscope Innovation, a full-spectrum product design, growth and insight company that innovates through the medical, consumer and industrial markets, enhancing smart product design capabilities. This follows on from the announcement made by the company on 3 September 2020.

This acquisition demonstrates Infosys’ commitment to innovate for its clients and to make a meaningful impact on human life through a combination of cutting-edge technologies. This collaboration also aims to revolutionise patient care, treatment, diagnostics and consumer health around the world.

With Kaleidoscope Innovation, Infosys will further strengthen its digital offerings as well as its workforce, with a diverse talent pool with extensive knowledge of design and engineering. Kaleidoscope leverages a broad understanding of healthcare settings, strong product development skills across disciplines, and consulting-style approach to human factors, product design, UI / UX design, study & insight, growth and visualisation. It serves a marquee and diversified client base of state-of-the-art, in-house laboratories, 3D design environments and customer experience centers.

Kaleidoscope innovation designs microsurgical equipment, devices used in minimally invasive surgery, drug delivery devices for ophthalmic treatments and user-centric wearables. It also provides usability testing to support regulatory submissions, including the delivery mechanism for aortic stents.